Journal of Business Chemistry February 2013

Abstract Personalised medicine is a discipline that integrates pharmaceutical development with existing knowledge about the genetic and phenotypic factors that influence drug response. This integration enables tailoring therapies to individual patient’s characteristics to help improve their safety and efficacy. Personalised medicine implies a shift in the way drugs are delivered as it requires new forms […]

Abstract Integrated production networks can be very efficient in using raw materials and energies resulting in optimized cost structures. In particular in the chemical industry integrated production networks gain competitive advantage. However, the complexity of large networks makes it difficult to predict and navigate through volatile markets and to define development strategies to meet future […]

Abstract The recent economic and financial crisis is considered global – as it has impacted national economies, business sectors, and companies. However, the impact of the crisis on a specific national economic system varies largely, case by case, both as intensity and lag time. The purpose of this paper is to present some of the […]

Abstract Technology licensing has been recognized for decades as one of the new market entry modes. Companies often issue licenses in foreign countries in order to enter a new market. This paper aims to unearth how companies manage the technology licensing, purposely used by firms in order to enter new markets. Starting from the perspectives […]